Next Article in Journal
Prognostic Role and Clinical Significance of Tumor-Infiltrating Lymphocyte (TIL) and Programmed Death Ligand 1 (PD-L1) Expression in Triple-Negative Breast Cancer (TNBC): A Systematic Review and Meta-Analysis Study
Previous Article in Journal
Automatic Prediction and Assessment of Treatment Response in Patients with Hodgkin’s Lymphoma Using a Whole-Body DW-MRI Based Approach
Previous Article in Special Issue
Clinical Impact of Sarcopenia and Inflammatory/Nutritional Markers in Patients with Unresectable Metastatic Urothelial Carcinoma Treated with Pembrolizumab
Open AccessReview

The Role of Imaging in Bladder Cancer Diagnosis and Staging

1
Department of Radiology, University of Alabama at Birmingham, Birmingham, AL 35249, USA
2
O’Neal Comprehensive Cancer Center at UAB, University of Alabama at Birmingham, Birmingham, AL 35249, USA
3
Department of Urology, University of Alabama at Birmingham, Birmingham, AL 35249, USA
*
Author to whom correspondence should be addressed.
Diagnostics 2020, 10(9), 703; https://doi.org/10.3390/diagnostics10090703
Received: 27 July 2020 / Revised: 2 September 2020 / Accepted: 10 September 2020 / Published: 16 September 2020
Bladder cancer (BC) is the most common cancer of the urinary tract in the United States. Imaging plays a significant role in the management of patients with BC, including the locoregional staging and evaluation for distant metastatic disease, which cannot be assessed at the time of cystoscopy and biopsy/resection. We aim to review the current role of cross-sectional and molecular imaging modalities for the staging and restaging of BC and the potential advantages and limitations of each imaging modality. CT is the most widely available and frequently utilized imaging modality for BC and demonstrates good performance for the detection of nodal and visceral metastatic disease. MRI offers potential value for the locoregional staging and evaluation of muscular invasion of BC, which is critically important for prognostication and treatment decision-making. FDG-PET/MRI is a novel hybrid imaging modality combining the advantages of both MRI and FDG-PET/CT in a single-setting comprehensive staging examination and may represent the future of BC imaging evaluation. View Full-Text
Keywords: urothelial carcinoma; magnetic resonance imaging; positron emission tomography; computed tomography; cancer staging; muscle-invasive bladder cancer urothelial carcinoma; magnetic resonance imaging; positron emission tomography; computed tomography; cancer staging; muscle-invasive bladder cancer
Show Figures

Figure 1

MDPI and ACS Style

Galgano, S.J.; Porter, K.K.; Burgan, C.; Rais-Bahrami, S. The Role of Imaging in Bladder Cancer Diagnosis and Staging. Diagnostics 2020, 10, 703.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop